- Home
- MOGO vs ELEV Comparison
MOGO vs ELEV Comparison
Compare MOGO & ELEV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGO
- ELEV
- Stock Information
- Founded
- MOGO 2003
- ELEV 2019
- Country
- MOGO Canada
- ELEV United States
- Employees
- MOGO N/A
- ELEV N/A
- Industry
- MOGO
- ELEV Biotechnology: Pharmaceutical Preparations
- Sector
- MOGO
- ELEV Health Care
- Exchange
- MOGO Nasdaq
- ELEV Nasdaq
- Market Cap
- MOGO 25.1M
- ELEV 22.6M
- IPO Year
- MOGO N/A
- ELEV 2021
- Fundamental
- Price
- MOGO $1.87
- ELEV $0.38
- Analyst Decision
- MOGO Strong Buy
- ELEV Hold
- Analyst Count
- MOGO 1
- ELEV 6
- Target Price
- MOGO $4.00
- ELEV $1.77
- AVG Volume (30 Days)
- MOGO 14.3M
- ELEV 1.1M
- Earning Date
- MOGO 08-07-2025
- ELEV 08-05-2025
- Dividend Yield
- MOGO N/A
- ELEV N/A
- EPS Growth
- MOGO N/A
- ELEV N/A
- EPS
- MOGO N/A
- ELEV N/A
- Revenue
- MOGO $28,873,274.00
- ELEV N/A
- Revenue This Year
- MOGO $59.16
- ELEV N/A
- Revenue Next Year
- MOGO $6.17
- ELEV N/A
- P/E Ratio
- MOGO N/A
- ELEV N/A
- Revenue Growth
- MOGO 0.62
- ELEV N/A
- 52 Week Low
- MOGO $0.74
- ELEV $0.22
- 52 Week High
- MOGO $3.83
- ELEV $3.28
- Technical
- Relative Strength Index (RSI)
- MOGO 59.73
- ELEV 55.33
- Support Level
- MOGO $1.17
- ELEV $0.36
- Resistance Level
- MOGO $3.83
- ELEV $0.39
- Average True Range (ATR)
- MOGO 0.24
- ELEV 0.01
- MACD
- MOGO 0.08
- ELEV -0.00
- Stochastic Oscillator
- MOGO 26.87
- ELEV 53.57
About MOGO Mogo Inc.
Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established global corporations and innovative fintech companies in Europe and Canada.
About ELEV Elevation Oncology Inc. Common stock
Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.